Skip to content
healthcare.dev

Sodium Polystyrene Sulfonate

NDC 35573-108, sodium polystyrene sulfonate, suspension, from Burel Pharmaceuticals, LLC.

Product NDC
35573-108
Status
Listed
Labeler
Burel Pharmaceuticals, LLC
Dosage form
SUSPENSION
Route
ORAL, RECTAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA214912
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/35573-108 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SODIUM POLYSTYRENE SULFONATE15 g/60mL
Package NDCNDC-11Package
35573-108-143557301081410 BOTTLE, UNIT-DOSE in 1 CARTON (35573-108-14) / 60 mL in 1 BOTTLE, UNIT-DOSE (35573-108-13)
35573-108-5735573010857473 mL in 1 BOTTLE (35573-108-57)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/8bbeae67-a7ff-4fa6-b21e-fb8617cd9197

Use it

Look up 35573-108 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/35573-108 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 35573-108. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.